Month: February 2020

Medicinal cannabis - what are patients asking their GP?

Medicinal Cannabis – what are patients asking their GP’s?

February 24, 2020

Around the world, there is a growing interest in the use of cannabis as a medicine. In New Zealand, a Medicinal Cannabis Scheme is currently being established to increase access to medicinal cannabis products. In light of this, we decided to ask kiwi General Practitioners (GPs) what patients have been...

Read more about this

Inhaled steroids may have similar effects, both positive and negative, to steroids taken by mouth for asthma

February 17, 2020

Asthma symptoms and flare-ups are caused by inflammation of the airways. To treat this, anti-inflammatory medication such as corticosteroids are often prescribed. Most people with asthma are treated with corticosteroids using an inhaler (inhaled corticosteroids). Usually, this would be at a dose which mostly has an effect within the airways....

Read more about this

Optimal asthma control: time for a new target

February 10, 2020

Day-to-day asthma treatment is widely based on a stepwise approach where care can be ‘stepped up’ to control symptoms, and ‘stepped down’ after a period of symptom control. We have written a review of potential problems with this approach.  Firstly, this model can only achieve ’total control’ of symptoms for...

Read more about this

The AIR algorithm: a new approach to asthma care based on evidence of better outcomes, safety, and ease of use for patients

February 3, 2020

We have proposed a new treatment model for day-to-day asthma care: the anti-inflammatory reliever therapy based algorithm (AIR algorithm for short), based on a 2-in-1 combination inhaler. Day-to-day asthma care usually involves taking two types of medicines: Maintenance: regular scheduled treatment to control asthma symptoms and reduce the risk of...

Read more about this